Tick (check) box to add article to PDF "basket"
An international team of researchers, led by ERC grantee Prof Rune Linding, discovered how genetic cancer mutations attack the networks controlling human cells. This knowledge is critical for the future development of personalized precision cancer treatments.
Published: 1 October 2015
Breast cancer is the leading cause of cancer deaths in women, with more than one million cases diagnosed in the world every year. The EU-funded BASIS project has reached a major milestone in characterising the different genetic mutations that lie behind this disease - defining the range of possibilities for drug development.
Published: 1 October 2015
Human papillomavirus has long been associated with the vast majority of cervical and anogenital cancers diagnosed worldwide, but its role in head-and-neck cancers has been less widely researched. In a landmark case study, EU-funded researchers are characterising the connection in order to advance the development of new screening and diagnostic techniques.
Published: 2 September 2015
EU-funded researchers have developed an innovative new cancer treatment. Interest from the pharmaceutical industry has been so great that the research team has set up a company dedicated to bringing their innovations to market.
Published: 1 September 2015
Researchers are blazing a trail towards personalised medicine in cancer care. This will mean the provision of new immunotherapy treatments targeting some of the most complicated conditions. In line with this approach an EU-funded project is developing new technologies to help doctors provide targeted, individual treatments. It has so far conducted clinical trials involving eight melanoma patients to demonstrate the potential of this approach.
Published: 18 August 2015
An EU-funded project is attempting to validate a prototype test designed to predict which combination therapy would best suit individual patients with colorectal cancer, the most common form of cancer in Europe. The test is expected to lengthen the life expectancy for those with this aggressive form of cancer by indicating the most effective treatment combination for individual patients.
Published: 13 August 2015
Breast cancer is a leading cause of death for women, despite screening programmes cutting mortality rates. EU-funded researchers have developed new tools for personalised screening programmes to improve detection and prognosis - several of which are ready for use.
Published: 29 July 2015
In Europe, some 463 000 women are diagnosed with breast cancer each year, making it the most common form of cancer in women. Depending on certain conditions, different drug combinations will be more - or less - effective. The EU-funded RESPONSIFY project has identified these conditions.
Published: 16 July 2015
Luckily, sarcomas are rare - but this also means that very few clinical trials have investigated better ways to tackle these malignant tumours. The fact that there are many types of sarcoma, which respond to treatment in very different ways, adds to the difficulty of organising such studies. An EU-funded cancer research project has taken up the challenge in a bid to develop targeted treatments.
Published: 14 July 2015
EU-funded researchers are developing innovative tools and 'liquid biopsy' techniques to improve the diagnosis and treatment of cancer by targeting the detached tumour cells that cause the vast majority of deaths. Once validated and commercialised, their approach promises to lead to more effective and personalised care for cancer patients.
Published: 9 June 2015